2018
DOI: 10.1017/s0033291718001186
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and determinants of cognitive impairment in the euthymic phase of bipolar disorders: results from the FACE-BD cohort

Abstract: This is the first study to validate a criterion for clinically significant cognitive impairment in BD. We report a lower prevalence of cognitive impairment than previous studies, which may have overestimated its prevalence. Patients with euthymic BD and cognitive impairment may benefit from cognitive remediation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
13
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 32 publications
0
13
1
Order By: Relevance
“…Furthermore, medication was not included in the models, although it has been reported to have an impact on cognition in bipolar disorder. 2 We only included in our models the concurrent level of depressive symptoms measured by MADRS, and did not include potential mood episodes that could have occurred between evaluations.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, medication was not included in the models, although it has been reported to have an impact on cognition in bipolar disorder. 2 We only included in our models the concurrent level of depressive symptoms measured by MADRS, and did not include potential mood episodes that could have occurred between evaluations.…”
Section: Discussionmentioning
confidence: 99%
“…Bipolar disorder is a prevalent and disabling mental disorder. 1 Bipolar disorder is associated with mild cognitive impairments, 2,3 which persist during periods of euthymia, with a prevalence between 4 and 67% 2 defined at usual clinically defined thresholds. Patients with bipolar disorder also experience deficits in psychosocial functioning, which persist during periods of euthymia.…”
mentioning
confidence: 99%
“…However, we believe that such an overestimation bias may have been controlled by the fact that the distribution-based estimates were computed on a sample of patients with stable functioning. The influence of mood symptoms (Bonnín et al ., 2014 ), medication (Roux et al ., 2019 ) and trauma (Jimenez et al ., 2017 ) has not been assessed in this study and these are variables that could have influenced the patient outcomes. Another significant limitation was the lack of a psychometrically validated MCID for the two gold-standard anchor measures (CGI-S and GAF), which were determined based on the expertise of the authors and how the two scales were elaborated and clinically anchored.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, more than half the individuals with BD experience significant functional impairment in several domains, such as family and social life and work, outside the acute phases of the illness (Sanchez-Moreno et al ., 2017 ). Some patients also present significant cognitive impairments even in the euthymic phase of the disorder (Roux et al ., 2019 ). Traditionally, outcomes for patients with BD have been defined as the reduction of mood symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…Despite optimal treatment with mood stabilizers and second-generation antipsychotics, social and neurocognitive dysfunction in BD remains a serious problem. It is reported that 60-70% of BD patients have varying degrees of impairment in social and occupational functions (Henry et al,2015) and BD patients still suffer from impairment of attention, memory, information processing speed and executive function even in the stable period (Roux et al,2019). Social functioning is traditionally involved in autonomy, study, work, have leisure time, and engage in social relationships (Zarate et al,2000).…”
Section: Introductionmentioning
confidence: 99%